Origin
Princeton
About Origin
Origin is a privately-held, clinical-stage biotechnology company developing a medical technology to deliver therapeutic molecules. It is mainly for the targeted delivery of nitric oxide, used to treat pain and inflammation, wounds, ulcers, and infections of the skin and soft tissues, enhancing and saving lives through applications in medicine and agribusiness.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $3.4M
- Last round: Series Unknown (Oct 2023)
- Website: originww.com
- Phone: 609 250 6000
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/origin-151534 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.